tirzepatide mode of action Mechanism Weight Loss & Blood Sugar Control The promise of tirzepatide: A

Relying on oral contraceptives may be risky, as tirzepatide could reduce their effectiveness

Understanding the relationship between units, milligrams, and concentration is not optional

GLP-1 medications may carry risks including thyroid C-cell tumors (including thyroid cancer) and medullary thyroid carcinoma (MTC)

For many people, this tradeoff is worth it

About ACHIEVE-3 and ACHIEVE clinical trial program ACHIEVE-3 (NCT06045221) is a Phase 3, 52-week, randomized, open-label trial evaluating the efficacy and safety of orforglipron compared with oral semaglutide in adults with type 2 diabetes inadequately controlled with metformin

Metformin is FDA-approved for type 2 diabetes management